dc.contributor.author | Ozyazgan, Yılmaz | |
dc.contributor.author | Senocak, Mustafa Şükrü | |
dc.contributor.author | Tuzun, Yalçın | |
dc.contributor.author | Yurdakul, Sebahattin | |
dc.contributor.author | Hamuryudan, Vedat | |
dc.contributor.author | Mat, C | |
dc.contributor.author | Uysal, O | |
dc.contributor.author | Yazici, Hasan | |
dc.date.accessioned | 2021-03-04T08:29:30Z | |
dc.date.available | 2021-03-04T08:29:30Z | |
dc.date.issued | 2001 | |
dc.identifier.citation | Yurdakul S., Mat C., Tuzun Y., Ozyazgan Y., Hamuryudan V., Uysal O., Senocak M. Ş. , Yazici H., "A double-blind trial of colchicine in Behcet's syndrome", ARTHRITIS AND RHEUMATISM, cilt.44, sa.11, ss.2686-2692, 2001 | |
dc.identifier.issn | 0004-3591 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_639030b9-5c1b-4d28-8537-ae26faa76b32 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/69319 | |
dc.description.abstract | Objective. Colchicine is a widely used treatment for Behcet's syndrome, even though in a previous 6-month controlled study, it was shown to be effective only in controlling erythema nodosum and arthralgias. We reassessed the effect of colchicine in Behcet's syndrome in a study conducted among a larger group of patients for 2 years. | |
dc.language.iso | eng | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.title | A double-blind trial of colchicine in Behcet's syndrome | |
dc.type | Makale | |
dc.relation.journal | ARTHRITIS AND RHEUMATISM | |
dc.contributor.department | , , | |
dc.identifier.volume | 44 | |
dc.identifier.issue | 11 | |
dc.identifier.startpage | 2686 | |
dc.identifier.endpage | 2692 | |
dc.contributor.firstauthorID | 3068 | |